This month’s cover story on mass spectrometry for the clinical lab is the first CLP has published on this topic, but I don’t believe it will be our last. According to sources at the FDA and the National Cancer Institute’s proteomics prog
Read More
As diagnostics come to depend on increasingly sophisticated knowledge of biomarkers, mass spec emerges as a tool with revolutionary potential.
Read MoreClovis Oncology Inc and Ventana Medical Systems Inc announced that they have entered into a collaboration agreement for the development of a human equilibrative nucleoside transporter 1 (hENT1) immunohistochemistry (IHC) assay.
Read MoreQIAGEN has announced the appointment of two high level members, Dr Pia Garguilo and Richard Watts, to the recently formed Pharma Business Development team.
Read More